Published in Lancet on November 13, 2010
Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction (2011) 1.93
Diet and physical activity for the prevention of noncommunicable diseases in low- and middle-income countries: a systematic policy review. PLoS Med (2013) 1.79
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis (2012) 1.29
Implementing and evaluating a program to facilitate chronic disease prevention and screening in primary care: a mixed methods program evaluation. Implement Sci (2014) 1.29
Non-communicable diseases (NCDs) in developing countries: a symposium report. Global Health (2014) 1.27
Priorities for developing countries in the global response to non-communicable diseases. Global Health (2012) 1.13
Salutogenesis and Ayurveda: indications for public health management. EPMA J (2011) 1.12
The unfolding counter-transition in rural South Africa: mortality and cause of death, 1994-2009. PLoS One (2014) 1.02
Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature. Global Health (2014) 1.02
Global prevention and control of NCDs: Limitations of the standard approach. J Public Health Policy (2015) 1.00
Complex systems analysis: towards holistic approaches to health systems planning and policy. Bull World Health Organ (2011) 1.00
An analysis of Liberia's 2007 national health policy: lessons for health systems strengthening and chronic disease care in poor, post-conflict countries. Global Health (2011) 0.99
Epilepsy treatment in sub-Saharan Africa: closing the gap. Afr Health Sci (2012) 0.98
Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam. Int J Hypertens (2012) 0.97
Assessing research activity on priority interventions for non-communicable disease prevention in low- and middle-income countries: a bibliometric analysis. Glob Health Action (2012) 0.97
Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks. Glob Public Health (2013) 0.96
The burden is great and the money little: Changing chronic disease management in low- and middle-income countries. J Glob Health (2012) 0.95
Health coaching by telephony to support self-care in chronic diseases: clinical outcomes from The TERVA randomized controlled trial. BMC Health Serv Res (2012) 0.95
Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open (2013) 0.94
Barriers in access to healthcare services for chronic patients in times of austerity: an empirical approach in Greece. Int J Equity Health (2014) 0.93
Finding a BETTER way: a qualitative study exploring the prevention practitioner intervention to improve chronic disease prevention and screening in family practice. BMC Fam Pract (2014) 0.92
Age and sex pattern of cardiovascular mortality, hospitalisation and associated cost in India. PLoS One (2013) 0.91
The politics of non-communicable diseases in the global South. Health Place (2015) 0.89
Partnership research on nutrition transition and chronic diseases in West Africa - trends, outcomes and impacts. BMC Int Health Hum Rights (2011) 0.89
A systematic review of active transportation research in Africa and the psychometric properties of measurement tools for children and youth. Int J Behav Nutr Phys Act (2014) 0.87
Developing clinical decision tools to implement chronic disease prevention and screening in primary care: the BETTER 2 program (building on existing tools to improve chronic disease prevention and screening in primary care). Implement Sci (2015) 0.87
Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. Nutr J (2011) 0.85
What Contributes to the Activeness of Ethnic Minority Patients with Chronic Illnesses Seeking Allied Health Services? A Cross-Sectional Study in Rural Western China. Int J Environ Res Public Health (2015) 0.85
Agenda setting and framing of gender-based violence in Nepal: how it became a health issue. Health Policy Plan (2015) 0.84
Multi-sectoral action for addressing social determinants of noncommunicable diseases and mainstreaming health promotion in national health programmes in India. Indian J Community Med (2011) 0.84
Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. Indian J Nephrol (2011) 0.83
Employers' views on the promotion of workplace health and wellbeing: a qualitative study. BMC Public Health (2015) 0.83
Musculoskeletal pain on the global stage: what next? Transl Behav Med (2012) 0.81
Trade liberalization and tuberculosis incidence: a longitudinal multi-level analysis in 22 high burden countries between 1990 and 2010. Health Policy Plan (2013) 0.81
Assessment of health service delivery capacities, health providers' knowledge and practices related to type 2 diabetes care in Kinshasa primary healthcare network facilities, Democratic Republic of the Congo. BMC Health Serv Res (2015) 0.81
The post-2015 development agenda: keeping our focus on the worst off. Am J Trop Med Hyg (2015) 0.81
Practicalities and challenges in re-orienting the health system in Zambia for treating chronic conditions. BMC Health Serv Res (2014) 0.81
Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS One (2014) 0.80
Withania somnifera: From prevention to treatment of cancer. Mol Nutr Food Res (2016) 0.80
Creating political priority for micronutrient deficiencies: a qualitative case study from Senegal. BMJ Open (2014) 0.79
Health awareness and popularity of alternative medicines among people of Jamnagar town: A cross - sectional study. Ayu (2012) 0.79
Putting teeth into chronic diseases. Lancet (2011) 0.77
Improving life expectancy: how many years behind has the USA fallen? A cross-national comparison among high-income countries from 1958 to 2007. BMJ Open (2013) 0.77
The Association of Age and Gender with Risk Factors of Noncommunicable Diseases among Employees in West of Iran. Int J Prev Med (2017) 0.75
Public health service options for affordable and accessible noncommunicable disease and related chronic disease prevention and management. J Multidiscip Healthc (2014) 0.75
Catastrophic Health Care Expenditure among Older People with Chronic Diseases in 15 European Countries. PLoS One (2016) 0.75
How to engage across sectors: lessons from agriculture and nutrition in the Brazilian School Feeding Program. Rev Saude Publica (2016) 0.75
Investing in a healthy lifestyle strategy: is it worth it? Int J Public Health (2016) 0.75
Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice. Heliyon (2016) 0.75
Malignancy risk models for oral lesions. Med Oral Patol Oral Cir Bucal (2013) 0.75
Chronic conditions and medical expenditures among non-institutionalized adults in the United States. Int J Equity Health (2014) 0.75
Social Support of Patients with Type 2 Diabetes in Marginalized Contexts in Mexico and Its Relation to Compliance with Treatment: A Sociocultural Approach. PLoS One (2015) 0.75
Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease. PLoS One (2015) 0.75
Physical inactivity in developing countries. CMAJ (2014) 0.75
Health and societal effects of alcohol. Lancet (2011) 0.75
Community Health Policy Assessment of a Rural Northeast Missouri County using the Centers for Disease Control and Prevention's CHANGE Tool. Health Promot Perspect (2013) 0.75
National Priority Setting of Clinical Practice Guidelines Development for Chronic Disease Management. J Korean Med Sci (2015) 0.75
Daughter-Initiated Cancer Screening Appeals to Mothers. J Cancer Educ (2016) 0.75
Improving the screening and treatment of hypertension in people living with HIV: An evidence-based policy brief by Malawi's Knowledge Translation Platform. Malawi Med J (2017) 0.75
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet (2009) 15.10
Preventing chronic diseases: how many lives can we save? Lancet (2005) 14.77
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Health effects of financial crisis: omens of a Greek tragedy. Lancet (2011) 8.45
Financial crisis, austerity, and health in Europe. Lancet (2013) 8.34
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med (2004) 8.07
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis (2009) 6.81
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet (2013) 6.19
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Where is the evidence that animal research benefits humans? BMJ (2004) 5.99
Mass privatisation and the post-communist mortality crisis: a cross-national analysis. Lancet (2009) 5.84
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57
Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens (2011) 5.54
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet (2005) 5.51
Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet (2007) 5.39
Outcomes of variation in hospital nurse staffing in English hospitals: cross-sectional analysis of survey data and discharge records. Int J Nurs Stud (2006) 5.37
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Embedding non-communicable diseases in the post-2015 development agenda. Lancet (2013) 5.15
Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol (2004) 5.07
Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet (2008) 4.97
Post-communist transition and health in Europe. BMJ (2004) 4.90
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Effects of the 2008 recession on health: a first look at European data. Lancet (2011) 4.80
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74
Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2011) 4.72
WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet (2008) 4.53
How to achieve international action on falsified and substandard medicines. BMJ (2012) 4.36
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis (2007) 4.34
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet (2008) 4.32
Increase in state suicide rates in the USA during economic recession. Lancet (2012) 4.28
Chronic diseases and injuries in India. Lancet (2011) 4.27
Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med (2006) 4.22
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
Prevention of chronic diseases: a call to action. Lancet (2007) 3.87
Suicides associated with the 2008-10 economic recession in England: time trend analysis. BMJ (2012) 3.87
Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ (2002) 3.87
Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet (2010) 3.82
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med (2007) 3.71
Why the GMC should set up a central registry of doctors' competing interests. BMJ (2014) 3.69
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68
NHS waiting lists and evidence of national or local failure: analysis of health service data. BMJ (2003) 3.60
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ (2005) 3.49
(Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol (2004) 3.43
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
The effect of the late 2000s financial crisis on suicides in Spain: an interrupted time-series analysis. Eur J Public Health (2013) 3.37
Lessons from the withdrawal of rofecoxib. BMJ (2004) 3.33
Drivers of inequality in Millennium Development Goal progress: a statistical analysis. PLoS Med (2010) 3.30
Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet (2002) 3.29
Migration and health in an increasingly diverse Europe. Lancet (2013) 3.24
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Chronic diseases and calls to action. Int J Epidemiol (2008) 3.11
Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet (2004) 3.11
WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ (2005) 3.09
Budget crises, health, and social welfare programmes. BMJ (2010) 3.08
Mortality trends and setbacks: global convergence or divergence? Lancet (2004) 3.08
Non-communicable diseases in low and middle-income countries: a priority or a distraction? Int J Epidemiol (2005) 3.06
Smoke free hospitals. BMJ (2003) 3.05
Preventing chronic diseases: taking stepwise action. Lancet (2005) 3.04
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03